Skip to main content
. 2015 Mar 26;10(3):e0118703. doi: 10.1371/journal.pone.0118703

Table 1. Characteristics of subjects with ESRD.

Patient Characteristics Plasma Markers
Patient Gender Age (Years) Etiology Time on Dialysis (Months 24 Hour Urine Output (Ounces) Pre-D Cr1 (mg/ml) Pre-D BUN (mg/dl) Post-D BUN (mg/dl) Pre-D IS2 (μg/ml) Post-D IS (μg/ml)
Residual Renal Function 1 M 47 DM3 36 12–18 9.38 63 20 70.21 44.14
2 M 70 DM 108 18–24 6.1 55 14 42.67 26.7
3 F 64 DM 3 18 4.45 42 7 12.32 5.71
4 M 59 DM 60 12 4.27 38 11 28.55 18.63
5 M 42 DM 7 9 7.25 63 21 28.33 19.41
No Residual Renal Function 6 M 28 Transplant Rejection 36 0 13.28 47 12 79.56 40.2
7 M 39 FSGS4 36 1 16.86 71 19 46.49 34.15
8 M 53 DM 84 1 7.98 63 15 65.09 44.29
9 F 32 DM 48 0 7.6 45 10 68.56 30.23
10 M 50 HTN5 180 0 8.58 73 18 27.89 13.07

The preponderance of patients with diabetic glomerulosclerosis reflects the exclusion of patients with active glomerulonephritis or other inflammatory processes and the predominance of diabetic glomeruosclerosis in our dialysis population. Abbreviations: 1 = Creatinine, 2 = indoxyl sulfate, 3 = diabetes mellitus, 4 = focal segmental glomerulosclerosis, 5 = hypertensive nephropathy.